Heimlich H J
Heimlich Institute, Cincinnati, OH.
Postgrad Med. 1988 Nov 1;84(6):68-73, 77-9. doi: 10.1080/00325481.1988.11700463.
Transtracheal oxygen delivery with the Micro-Trach is state-of-the-art treatment for patients requiring long-term oxygen therapy. The Micro-Trach diminishes dyspnea because it bypasses the anatomic dead space in the respiratory tract. It eliminates the waste of oxygen that escapes from the nose and mouth when a nasal cannula is used. Therefore, a small oxygen container lasts longer, increasing the patient's mobility. The patient's appetite improves because oxygen is not diverted during deglutition, and the senses of smell and taste are restored. Rehabilitation is enhanced through increased mobility and improved nutrition. Transtracheal instillation of saline solution cleanses the respiratory tract and stimulates coughing, opening occluded air passages. There are fewer lung infections and hospitalizations for infective exacerbations of disease. Prescribed saline solution, mucolytics, and antibiotics can also be instilled through the Micro-Trach to treat cystic fibrosis. This use and others are still being explored.
使用微型气管造口术进行经气管输氧是需要长期氧疗的患者的先进治疗方法。微型气管造口术可减轻呼吸困难，因为它绕过了呼吸道中的解剖死腔。它消除了使用鼻导管时从鼻子和嘴巴逸出的氧气浪费。因此，一个小氧气罐能持续更长时间，增加了患者的活动能力。患者的食欲有所改善，因为吞咽时氧气不会被转移，嗅觉和味觉也得以恢复。通过增加活动能力和改善营养，康复进程得到加强。经气管滴注盐水可清洁呼吸道并刺激咳嗽，打开堵塞的气道。肺部感染以及因疾病感染加重而住院的情况减少。规定的盐水、黏液溶解剂和抗生素也可通过微型气管造口术注入以治疗囊性纤维化。这种用途及其他用途仍在探索中。
